Doximity [DOCS] vs Ge Healthcare [GEHC] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 21 vital metrics comparison: Doximity Inc. wins in 7 metrics, Ge Healthcare Technologies Inc. wins in 13 metrics, with 0 ties. Ge Healthcare Technologies Inc. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Doximity Inc. | Ge Healthcare Technologies Inc. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 20.29 | 15.92 | Ge Healthcare Technologies Inc. |
| Price-to-Book Ratio | 4.56 | 3.18 | Ge Healthcare Technologies Inc. |
| Debt-to-Equity Ratio | 1.09 | 98.72 | Doximity Inc. |
| PEG Ratio | -1.16 | -0.87 | Ge Healthcare Technologies Inc. |
| EV/EBITDA | 15.22 | 10.74 | Ge Healthcare Technologies Inc. |
| Profit Margin (TTM) | 37.54% | 10.10% | Doximity Inc. |
| Operating Margin (TTM) | 38.89% | 15.73% | Doximity Inc. |
| EBITDA Margin (TTM) | 38.89% | 15.73% | Doximity Inc. |
| Return on Equity | 23.82% | 22.38% | Doximity Inc. |
| Return on Assets (TTM) | 12.84% | 5.47% | Doximity Inc. |
| Free Cash Flow (TTM) | $266.74M | $1.51B | Ge Healthcare Technologies Inc. |
| Dividend Yield | N/A | 0.25% | N/A |
| 1-Year Return | -58.92% | -11.62% | Ge Healthcare Technologies Inc. |
| Price-to-Sales Ratio (TTM) | 7.13 | 1.60 | Ge Healthcare Technologies Inc. |
| Enterprise Value | $3.74B | $39.12B | Ge Healthcare Technologies Inc. |
| EV/Revenue Ratio | 5.86 | 1.90 | Ge Healthcare Technologies Inc. |
| Gross Profit Margin (TTM) | 89.89% | 39.68% | Doximity Inc. |
| Revenue per Share (TTM) | $3 | $45 | Ge Healthcare Technologies Inc. |
| Earnings per Share (Diluted) | $1.19 | $4.55 | Ge Healthcare Technologies Inc. |
| Beta (Stock Volatility) | 1.42 | 1.31 | Ge Healthcare Technologies Inc. |
| Short % of Float | 10.09% | 3.07% | Ge Healthcare Technologies Inc. |
Doximity Inc. vs Ge Healthcare Technologies Inc. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Doximity Inc. | -2.19% | 10.19% | -13.58% | -16.30% | -57.46% | -50.31% |
| Ge Healthcare Technologies Inc. | 0.06% | -3.41% | 1.62% | -22.67% | -22.73% | -25.15% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Doximity Inc. | -58.92% | -35.21% | -61.77% | -61.77% | -61.77% | -61.77% |
| Ge Healthcare Technologies Inc. | -11.62% | -22.05% | 9.87% | 9.87% | 9.87% | 9.87% |
Performance & Financial Health Analysis: Doximity Inc. vs Ge Healthcare Technologies Inc.
| Metric | DOCS | GEHC |
|---|---|---|
| Market Information | ||
| Market Cap | $4.36B | $31.89B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 3,524,245 | 2,502,586 |
| 90 Day Avg. Volume | 2,884,808 | 3,405,145 |
| Last Close | $21.04 | $62.03 |
| 52 Week Range | $17.15 - $76.51 | $58.75 - $89.77 |
| % from 52W High | -72.50% | -30.90% |
| All-Time High | $107.79 (Sep 06, 2021) | $94.80 (Feb 10, 2025) |
| % from All-Time High | -80.48% | -34.57% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.10% | 0.07% |
| Quarterly Earnings Growth | -0.18% | -0.18% |
| Financial Health | ||
| Profit Margin (TTM) | 0.38% | 0.10% |
| Operating Margin (TTM) | 0.39% | 0.16% |
| Return on Equity (TTM) | 0.24% | 0.22% |
| Debt to Equity (MRQ) | 1.09 | 98.72 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $5.29 | $22.77 |
| Cash per Share (MRQ) | $3.98 | $9.86 |
| Operating Cash Flow (TTM) | $315.42M | $1.99B |
| Levered Free Cash Flow (TTM) | $213.63M | $1.69B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.25% |
| Last 12-Month Dividend | N/A | $0.20 |
Valuation & Enterprise Metrics Analysis: Doximity Inc. vs Ge Healthcare Technologies Inc.
| Metric | DOCS (Apr 24, 2026) | GEHC (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 20.29 | 15.92 |
| Forward P/E | 14.90 | 13.02 |
| PEG Ratio | -1.16 | -0.87 |
| Price to Sales (TTM) | 7.13 | 1.60 |
| Price to Book (MRQ) | 4.56 | 3.18 |
| Market Capitalization | ||
| Market Capitalization | $4.36B | $31.89B |
| Enterprise Value | $3.74B | $39.12B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 5.86 | 1.90 |
| Enterprise to EBITDA | 15.22 | 10.74 |
| Risk & Other Metrics | ||
| Beta | 1.42 | 1.31 |
| Book Value per Share (MRQ) | $5.29 | $22.77 |
Financial Statements Comparison: Doximity Inc. vs Ge Healthcare Technologies Inc.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | DOCS (2025) | GEHC (2025) |
|---|---|---|
| Revenue/Sales | 570.40M | 20.63B |
| Cost of Goods Sold | 55.87M | 12.38B |
| COGS % of Revenue | 9.8% | 60.0% |
| Gross Profit | 514.53M | 8.25B |
| Gross Margin | 90.2% | 40.0% |
| Research & Development | 93.04M | 1.26B |
| Operating Income (EBIT) | 230.10M | 2.76B |
| Operating Margin | 40.3% | 13.4% |
| EBITDA | 242.90M | 3.69B |
| EBITDA Margin | 42.6% | 17.9% |
| Pre-Tax Income | 263.57M | 2.77B |
| Pre-Tax Income % of Revenue | 46.2% | 13.4% |
| Income Tax | 40.39M | 614.00M |
| Income Tax % of Revenue | 7.1% | 3.0% |
| Net Income (Profit) | 223.19M | 2.15B |
| Profit Margin | 39.1% | 10.4% |
Balance Sheet & Liquidity Metrics
| Metric | DOCS (2025) | GEHC (2025) |
|---|---|---|
| Cash & Equivalents | 209.61M | 4.49B |
| Total Current Assets | 1.09B | 12.50B |
| Total Current Assets % of Revenue | 190.9% | 60.6% |
| Total Current Liabilities | 156.26M | 9.11B |
| Total Current Liabilities % of Revenue | 27.4% | 44.1% |
| Long-Term Debt | 10.19M | 9.82B |
| Long-Term Debt % of Revenue | 1.8% | 47.6% |
| Total Shareholders Equity | 1.08B | 10.60B |
| Retained Earnings | 186.89M | 5.28B |
| Retained Earnings % of Revenue | 32.8% | 25.6% |
| Property, Plant & Equipment | 8.89M | 410.00M |
Cash Flow Statement Comparison
| Metric | DOCS (2025) | GEHC (2025) |
|---|---|---|
| Operating Cash Flow | 279.85M | 3.02B |
| Operating Cash Flow % of Revenue | 49.1% | 14.6% |
| Capital Expenditures | 0 | -482.00M |
| Free Cash Flow | 266.74M | 1.51B |
| FCF Margin | 46.8% | 7.3% |
| Debt Repayment | N/A | -1.77B |
| Common Stock Repurchase | -120.29M | -200.00M |
Short Interest & Institutional Ownership Analysis
| Metric | DOCS | GEHC |
|---|---|---|
| Shares Short | 13.20M | 12.36M |
| Short Ratio | 4.99 | 3.20 |
| Short % of Float | 10.09% | 3.07% |
| Shares Outstanding | 184.99M | 455.74M |
| Float Shares | 130.57M | 454.48M |
| % Held by Insiders | 2.59% | 0.35% |
| % Held by Institutions | 93.77% | 93.39% |
| % Held by Public | 3.64% | 6.26% |
Dividend Analysis & Yield Comparison: Doximity Inc. vs Ge Healthcare Technologies Inc.
| Metric | DOCS | GEHC |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.20 |
| Last 12-Month Dividend Yield | N/A | 0.25% |
| 3-Year Avg Annual Dividend | N/A | $0.15 |
| 3-Year Avg Dividend Yield | N/A | 0.04% |
| 3-Year Total Dividends | N/A | $0.45 |
| Ex-Dividend Date | N/A | Apr 02, 2026 |